NEXEF-SB Injection
Power of Ceftriaxone Potentiated by Tazobactam
COMPOSITION:
- NEXEF-SB 375 Inj.: Ceftriaxone-250mg + Sulbactam 125mg
- NEXEF-SB 750 Inj.: Ceftriaxone 500mg + Sulbactam 250mg
- NEXEF-SB Inj.: Ceftriaxone-1000mg + Sulbactam 500mg
- NEXEF-TBZ Inj.: Sterile Ceftriaxone Sodium U.S.P1000mg +Sterile Tazobactam Sodium 125mg
Description
NEXEF-SB Injection
COMPOSITION:
- NEXEF-SB 375 Inj.: Ceftriaxone-250mg + Sulbactam 125mg
- NEXEF-SB 750 Inj.: Ceftriaxone 500mg + Sulbactam 250mg
- NEXEF-SB Inj.: Ceftriaxone-1000mg + Sulbactam 500mg
- NEXEF-TBZ Inj.: Sterile Ceftriaxone Sodium U.S.P1000mg +Sterile Tazobactam Sodium 125mg
Ceftriaxone
- Ceftriaxone is a new semisynthetic cephalosporin with broad-spectrum in vitro activity and an unusually long serum half-life.
- It is a safe and effective antibiotic for therapy of serious bacterial infections.
- Offers tissue concentration much higher than MIC for many virulent pathogens.1
Tazobactam
- Helps ceftriaxone in regaining sensitivity against resistant strains
- Payne et al. reported that tazobactam has greater β lactamases inhibitory activity than sulbactam.2
Combination
- The combination of ceftriaxone and tazobactam in the ratio of 8:1 can be an effective treatment to combat extended spectrum beta-lactamase producing E. coli infections.